Skip to main content
Clinical Trials/NCT01479751
NCT01479751CompletedNot Applicable

Comparison of Mg, Ketamine, Large Dose Rocuronium, and Priming on Intubating Condition in Rapid Sequence Intubation

Seoul National University Bundang Hospital1 site in 1 country110 target enrollmentStarted: November 2011Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
110
Locations
1
Primary Endpoint
Intubation score

Study Overview

Brief Summary

In this study, methods which are known for facilitating rapid sequence intubation or accelerating rocuronium (Roc)onset are compared including magnesium (Mg), ketamine pretreatment, large dose rocuronium and priming.

Detailed Description

Patients are pretreated with Mg, ketamine, or priming dose Roc. Two groups do not receive pretreatment, but are given Roc 0.6 mg/kg or 0.9 mg/kg.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • age 18 - 65 years,
  • ASA 1 - 2,
  • patients scheduled for elective surgery under general anesthesia,
  • BMI 18.5-24.9 kg/m2
  • Mallampati class I-II

Exclusion Criteria

  • neuromuscular disorder,
  • cardiac/hepatic/renal insufficiency,
  • pregnant.
  • anticipated difficult airway
  • medications that influence neuromuscular transmission

Arms & Interventions

priming

Experimental

Patients receive Roc 0.06 mg/ kg as a priming dose 3 min before injection of Roc 0.54 mg/kg.

Intervention: rocuronium (Drug)

ketamine

Experimental

Patients receive ketamine 0.5 mg/kg 2 min before Roc injection.

Intervention: Ketamine (Drug)

Mg

Experimental

Patients receive magnesium sulfate (MgSO4) 50 mg/kg over 10 min before Roc injection.

Intervention: Magnesium Sulfate (Drug)

Outcomes

Primary Outcomes

Intubation score

Time Frame: participants will be followed at the time point of intubation, an expected average of 70 sec from the start of rocuronium injection.

Patients are tracheally intubated, and intubation scores(poor, good,excellent)are rated.

Secondary Outcomes

  • Roc onset(participants will be followed when TOFcount =0 within an expected average of 4 min from the start of rocuronium injection.)
  • Roc duration(participants will be followed when TOF count reaches two, an expected average of 40 min.)
  • Hemodynamic variables(participants will be followed at baseline, before and for 5 min after the intubation, an expected average of 8 min after the start of anesthetic induction.)
  • TOF% at intubation(participants will be followed at the time point of intubation, an expected average of 70 sec from the start of rocuronium injection.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kim Mihyun

clinical professor

Seoul National University Bundang Hospital

Study Sites (1)

Loading locations...

Similar Trials